Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial.

Source:http://linkedlifedata.com/resource/pubmed/id/10683349

Circulation 2000 Feb 22 101 7 758-64

Download in:

View as

General Info

PMID
10683349